Sprintec Kit
Product Images NDC 0555-9016

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sprintec (NDC 0555-9016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
This is a description of a medication called "Sprintec tablets USP". The tablets contain a combination of norgestimate and ethinyl estradiol, with a strength of 0.250 mg/0.035 mg. The recommended storage temperature is between 20°C to 25°C. The name of the company selling the medication is not available.*
FDA Label Image

Image 2

FDA Label Image

Image 3

FDA Label Image

Image 4

FDA Label Image

Image 5

Image 5
This text discusses various methods for birth control, including implants, injections, intrauterine devices, sterilization, birth control pills, a skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during the most fertile days of the monthly cycle, spermicide, and withdrawal.*
FDA Label Image

Image 6

Image 6
This is a description for a medication called "Sprintec Tablets USP," which contains two active ingredients: norgestimate and ethinyl estradiol. It comes in a dosage strength of 0.250 mg/0.035 mg. The text also includes storage instructions: the medication should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) according to USP Controlled Room Temperature guidelines. The name of the company selling the medication is not clear due to the text, and some characters are illegible.*
FDA Label Image

Image 7

Image 7
This is a medication packaging of Norgestimate and Ethinyl Estradiol tablets. The tablets are in a blister card format with 6 cards and 28 tablets each. The usual dosage of the pills is one tablet daily, for 28 consecutive days per menstrual cycle. There are 21 blue tablets followed by 7 white tablets, as prescribed. The medication must be stored between 20° to 25°C and protected from light. The label also includes necessary cautionary warnings and contact information of the pharmaceutical company.*
FDA Label Image

Image 8

Image 8
This is a product description for a package of oral contraceptive pills with the brand name "Bistor Cards". The package contains 6 blister cards, each of which has 28 tablets. 21 blue tablets each contain 0.250 mg norgestimate and 0.035 mg ethinyl estradiol, while 7 white tablets contain inert ingredients. The product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases. The package has a unique identification number (NDC 0555-9016-58) and a barcode (GTIN 005559016589). The package is designed for shaping women's health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.